QuidelOrtho (LTS:0A55) Cyclically Adjusted PS Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0A55 QuidelOrtho Corp LTS:0A55
47 GF Score
Price $13.56
GF Value $26.41
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is QuidelOrtho Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


QuidelOrtho  (LTS:0A55) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


QuidelOrtho Cyclically Adjusted PS Ratio Related Terms


QuidelOrtho Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for QuidelOrtho's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho Cyclically Adjusted PS Ratio Chart

QuidelOrtho Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.05 4.01 2.85 1.48 0.84

QuidelOrtho Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.88 0.84 0.46 0.00

LTS:0A55 vs LMRI, AVNS, TNDM: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, QuidelOrtho's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Cyclically Adjusted PS Ratio falls into.


LTS:0A55
47GF Score
QuidelOrtho Corp LTS:0A55
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QuidelOrtho Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

QuidelOrtho's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, QuidelOrtho's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=9.237/333.9520*333.9520
=9.237

Current CPI (Jun. 2026) = 333.9520.

QuidelOrtho Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.510 241.428 2.089
201612 1.605 241.432 2.220
201703 2.168 243.801 2.970
201706 1.142 244.955 1.557
201709 1.501 246.819 2.031
201712 3.347 246.524 4.534
201803 4.032 249.554 5.396
201806 2.720 251.989 3.605
201809 2.737 252.439 3.621
201812 3.097 251.233 4.117
201903 3.449 254.202 4.531
201906 2.613 256.143 3.407
201909 2.928 256.759 3.808
201912 3.515 256.974 4.568
202003 4.024 258.115 5.206
202006 4.612 257.797 5.974
202009 10.920 260.280 14.011
202012 18.552 260.474 23.785
202103 8.622 264.877 10.870
202106 4.165 271.696 5.119
202109 11.995 274.310 14.603
202112 14.442 278.802 17.299
202203 23.639 287.504 27.458
202206 11.595 296.311 13.068
202209 11.612 296.808 13.065
202212 12.933 296.797 14.552
202303 12.610 301.836 13.952
202306 9.957 305.109 10.898
202309 11.121 307.789 12.066
202312 11.117 306.746 12.103
202403 10.628 312.332 11.364
202406 9.493 314.175 10.091
202409 10.804 315.301 11.443
202412 10.486 315.605 11.096
202503 10.264 319.799 10.718
202506 9.068 322.561 9.388
202509 10.293 324.800 10.583
202512 10.626 324.054 10.951
202603 9.088 330.213 9.191
202606 9.237 333.952 9.237

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is QuidelOrtho (LTS:0A55) Overvalued in 2026?

Based on GuruFocus' analysis, QuidelOrtho stock appears to be undervalued. The current stock price of $13.56 is trading 48.7% below its estimated GF Value™ of $26.41. GuruFocus considers QuidelOrtho to be Possible Value Trap.

Key valuation signals for LTS:0A55:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $26.41 vs. price of $13.56 (48.7% below fair value)
  • GF Score™: 47/100 with 8 warning signs

No single metric tells the full story. See the LTS:0A55 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


QuidelOrtho Business Description

Other Exchanges QDEL:USAQL1A:Germany
Address 9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
47GF Score

Get the complete analysis for LTS:0A55

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.56
Price
$26.41
GF Value